Relx Plc $RELX Stock: Prime Capital Investment Advisors LLC Reduces Holdings

Prime Capital Investment Advisors LLC lessened its holdings in shares of Relx Plc (NYSE:RELX) by 57.0% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 17,496 shares of the technology company’s stock after selling 23,172 shares during the quarter. Prime Capital Investment Advisors LLC’s holdings in Relx were worth $581,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in RELX. Arrowstreet Capital Limited Partnership lifted its stake in Relx by 185.7% in the first quarter. Arrowstreet Capital Limited Partnership now owns 4,252,044 shares of the technology company’s stock valued at $140,955,000 after acquiring an additional 2,763,766 shares during the last quarter. Bank of America Corp DE grew its position in Relx by 14.3% in the first quarter. Bank of America Corp DE now owns 4,180,034 shares of the technology company’s stock worth $138,568,000 after acquiring an additional 522,619 shares in the last quarter. Lazard Asset Management LLC increased its stake in shares of Relx by 12.1% during the 1st quarter. Lazard Asset Management LLC now owns 3,040,217 shares of the technology company’s stock worth $100,783,000 after purchasing an additional 328,282 shares during the last quarter. Royal Bank of Canada increased its stake in shares of Relx by 12.1% during the 1st quarter. Royal Bank of Canada now owns 1,736,295 shares of the technology company’s stock worth $57,558,000 after purchasing an additional 187,132 shares during the last quarter. Finally, Sei Investments Co. increased its stake in shares of Relx by 25.3% during the 1st quarter. Sei Investments Co. now owns 528,854 shares of the technology company’s stock worth $17,531,000 after purchasing an additional 106,777 shares during the last quarter. Institutional investors own 15.02% of the company’s stock.

Relx Stock Performance

Shares of Relx stock opened at $40.53 on Friday. The company has a quick ratio of 0.40, a current ratio of 0.45 and a debt-to-equity ratio of 5.23. The stock has a 50 day moving average price of $35.43 and a two-hundred day moving average price of $34.46. Relx Plc has a 12-month low of $27.57 and a 12-month high of $46.97.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on RELX shares. TD Securities upgraded shares of Relx to a “strong-buy” rating in a report on Friday, September 11th. The Goldman Sachs Group reiterated a “buy” rating on shares of Relx in a report on Tuesday, June 30th. Weiss Ratings raised shares of Relx from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 7th. Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a report on Sunday, September 13th. Finally, TD Cowen initiated coverage on Relx in a report on Thursday, September 10th. They set a “buy” rating on the stock. Two equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy”.

About Relx

RELX PLC is a global information-based analytics and decision tools company serving professional and business customers. The company provides data, software, research, and workflow solutions that help organizations make decisions, manage risk, improve productivity, and access specialized knowledge.

Its main business areas include scientific, technical, and medical information; risk and business analytics; legal information and technology; and industry-focused events. Products and services include research platforms such as ScienceDirect and Scopus, legal research and workflow solutions offered through LexisNexis, and risk-management, fraud-prevention, and identity solutions provided through LexisNexis Risk Solutions.

RELX serves customers internationally, including universities, researchers, law firms, government agencies, insurers, financial institutions, corporations, and healthcare professionals.